# Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer

> **NCT00159445** · PHASE2 · COMPLETED · sponsor: **University of Southern California** · enrollment: 53 (estimated)

## Conditions studied

- Colorectal Cancer
- Colon Cancer

## Interventions

- **DRUG:** gemcitabine, capecitabine

## Key facts

- **NCT ID:** NCT00159445
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2007-03
- **Final completion:** 2007-11
- **Target enrollment:** 53 (ESTIMATED)
- **Last updated:** 2014-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00159445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00159445, "Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT00159445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*